BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27366097)

  • 1. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
    Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
    Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
    Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
    Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
    Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
    BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.
    Gharaee N; Pourali L; Jafarian AH; Hashemy SI
    Mol Biol Rep; 2018 Dec; 45(6):2257-2262. PubMed ID: 30225581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
    Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
    Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
    Davoodian M; Boroumand N; Mehrabi Bahar M; Jafarian AH; Asadi M; Hashemy SI
    Mol Biol Rep; 2019 Feb; 46(1):1285-1293. PubMed ID: 30684188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
    Wang F; Liu S; Liu J; Feng F; Guo Y; Zhang W; Zheng G; Wang Q; Cai L; Guo M; Lian X; Xu G; Zhang H
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1210-1216. PubMed ID: 31109645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration and validation of the Ki67, Her-2, and mutant P53 protein-based risk model, nomogram and lymph node metastasis model for predicting colorectal cancer progression and prognosis.
    Yuan C; Huang J; Wang Y; Xiao H
    Front Oncol; 2023; 13():1236441. PubMed ID: 38074671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.
    Shao W; Wang Q; Wang F; Jiang Y; Xu M; Xu J
    Onco Targets Ther; 2016; 9():477-87. PubMed ID: 26889086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of CCBE1 expression in human colorectal cancer.
    Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
    Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients.
    Fang W; Fu C; Chen X; Mou X; Liu F; Qian J; Zhao P; Zheng Y; Zheng YI; Deng J; Ye P; Wang Y; Zheng S
    Oncol Lett; 2015 May; 9(5):2003-2006. PubMed ID: 26137002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
    Ebrahimi S; Javid H; Alaei A; Hashemy SI
    Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High NUCB2 expression level is associated with metastasis and may promote tumor progression in colorectal cancer.
    Xie J; Chen L; Chen W
    Oncol Lett; 2018 Jun; 15(6):9188-9194. PubMed ID: 29805650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance.
    Jin R; Luo Z; Jun-Li ; Tao Q; Wang P; Cai X; Jiang L; Zeng C; Chen Y
    Front Oncol; 2023; 13():1023292. PubMed ID: 36874086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.